5347 篇
13897 篇
477387 篇
16218 篇
11751 篇
3898 篇
6510 篇
1243 篇
75477 篇
37463 篇
12122 篇
1645 篇
2846 篇
3402 篇
641 篇
1237 篇
1968 篇
4899 篇
3853 篇
5414 篇
全球人生长激素市场报告(2015-2019年)
Global Human Growth Hormone Market 2015-2019
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Human Growth Hormone
06.1.1 Introduction
Human Growth Hormone
06.1.2 Mechanism of Action
06.1.3 Growth Hormone Levels
Population Group
Growth Hormone Levels (ng/mL)
06.1.4 Growth Hormone Deficiency
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Geographical Segmentation
08.1 Human Growth Hormone Market in Americas
08.1.1 Market Size and Forecast
08.2 Human Growth Hormone Market in EMEA Region
08.2.1 Market Size and Forecast
08.3 Human Growth Hormone Market in APAC Region
08.3.1 Market Size and Forecast
09. Key Leading Countries
09.1 US
09.2 Japan
09.3 Germany
09.4 Italy
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2014
17.2.1 Merck Serono
17.2.2 Pfizer
17.2.3 Novo Nordisk
17.2.4 F. Hoffmann-La Roche
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 F. Hoffmann-La Roche
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Business Segmentation
18.1.4 Business Segmentation by Revenue 2012 and 2013
18.1.5 Geographical Segmentation by Revenue
18.1.6 Business Strategy
18.1.7 Key Information
18.1.8 SWOT Analysis
18.2 Merck Serono
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Geographical Segmentation by Revenue 2013
18.2.4 Business Strategy
18.2.5 Recent Developments
18.2.6 SWOT Analysis
18.3 Novo Nordisk
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation by Revenue 2013
18.3.4 Business Segmentation by Revenue 2012 and 2013
18.3.5 Sales by Geography
18.3.6 Business Strategy
18.3.7 Key Information
18.3.8 SWOT Analysis
18.4 Pfizer
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Business Segmentation by Revenue 2013
18.4.4 Business Segmentation by Revenue 2012 and 2013
18.4.5 Geographical Segmentation by Revenue
18.4.6 Business Strategy
18.4.7 Key Developments
18.4.8 SWOT Analysis
19. Other Reports in this Series